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Systemic Onset Juvenile Idiopathic Arthritis (SoJIA) is
characterized by systemic inflammation and chronic
arthritis. Intriguingly, the IL-18-NK cell axis seems to be
disturbed in the majority of SoJIA patients. The
observed NK cell dysfunction in SoJIA patients contri-
butes to important features of the disease including the
susceptibility for macrophage activation syndrome. Here
we describe the effects of Anakinra mono treatment on
the IL-18-NK cel axis in steroid naïve SoJIA patients. In
this study sixteen consecutive patients diagnosed with
systemic onset JIA were included. Clinical response to
Anakinra was evaluated using the validated core set
parameters for JIA as well as several biochemical para-
meters of disease activity.
In this cohort we show a good clinical response to
Anakinra in 14/16 patients SoJIA patients prior to stan-
dard steroid treatment. After 3 weeks of treatment 75%
of patients achieved a pACR90 score. Clinical improve-
ment was accompanied by normalization of IL-1, IL-6
and IL-18 levels in plasma. Interestingly, the use of Ana-
kinra in patients with short disease duration induces
restoration of the IL-18 - NK cell axis resulting in
improved lytic NK cell function and regaining of the
NK cell responsiveness to IL-18 stimulation. Moreover,
Anakinra seems to down regulate inflammasome activa-
tion. These data suggest that the mechanisms of inflam-
matory control induced by Anakinra in SoJIA patients
involves more than blocking IL-1R signaling, since it
seems to restore the IL-18-NK cell route as well.
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